Inclusion Criteria:
  -  School children, of public schools in villages of Saint Louis region (Senegal), female or male, 8 to 11 years old (inclusive) at the time of inclusion.
  -  Residence in the area during the period of the study.
  -  Free of obvious/severe health problems except schistosomiasis, as established by clinical examination.
  -  Written informed consent to participate obtained from subject's parents or legal guardian.
  -  Free of obvious/severe health problems except schistosomiasis, established by blood analysis, i.e. hematological exams, liver and renal function tests.
  -  Treated with 40mg/kg Praziquantel (PZQ) before inclusion (W-2 to W-4 before the first injection) in case of infection with S. mansoni and S. haematobium
  -  Children of Group 1: not infected, no schistosomiasis history and living in area/village free of Sm and Sh transmission.
  -  Children Groups 2 & 3: infected with mansoni or/and haematobium schistosomiasis.
Exclusion Criteria:
  -  School child who does not respond to one of the inclusion criteria
  -  Child under 20kg of body weight
  -  Vaccination within 90 days preceding the first dose of Sm14 vaccine candidate, or planned use during the study period.
  -  Current or previous chronic administration (defined as more than 14 days) of immunosuppressive drugs or other immuno-modifying drugs.
  -  Known hypersensitivity to any component in the Sm14 vaccine or history of allergic disease.
  -  Knowledge of non-infectious chronic disease
  -  Known acute disease.
  -  Other conditions which in opinion of the PI may potentially represent a danger for the patient to be enrolled.